Literature DB >> 31822306

Sex Differences in Cognitive Changes in De Novo Parkinson's Disease.

Ece Bayram1, Sarah J Banks1, Guogen Shan2, Nikki Kaplan3, Jessica Z K Caldwell3.   

Abstract

OBJECTIVE: To evaluate the sex differences in cognitive course over 4 years in Parkinson's disease (PD) patients with and without mild cognitive impairment (MCI) compared to controls.
METHODS: Four-year longitudinal cognitive scores of 257 cognitively intact PD, 167 PD-MCI, and 140 controls from the Parkinson's Progression Markers Initiative were included. Longitudinal scores of men and women, and PD with and without MCI were compared.
RESULTS: Women had better verbal memory, men had better visuospatial function. There was no interaction between sex, diagnostic group, and/or time (4-year follow-up period).
CONCLUSIONS: Sex differences in cognitive course in de novo PD are similar to healthy aging. Cognitive decline rates in PD with and without MCI are similar for the first 4 years of PD.

Entities:  

Keywords:  Cognition; Decline; Longitudinal studies; Memory; Parkinson’s disease; Sex

Mesh:

Year:  2019        PMID: 31822306      PMCID: PMC7282562          DOI: 10.1017/S1355617719001085

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  25 in total

1.  Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.

Authors:  Shanna L Burke; Tianyan Hu; Nicole M Fava; Tan Li; Miriam J Rodriguez; Katie L Schuldiner; Aaron Burgess; Angela Laird
Journal:  J Women Aging       Date:  2018-01-10

2.  The influence of vascular risk factors on cognitive function in early Parkinson's disease.

Authors:  Maxime Doiron; Mélanie Langlois; Nicolas Dupré; Martine Simard
Journal:  Int J Geriatr Psychiatry       Date:  2017-05-16       Impact factor: 3.485

3.  Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson's disease and their carers in the community.

Authors:  J Meara; E Mitchelmore; P Hobson
Journal:  Age Ageing       Date:  1999-01       Impact factor: 10.668

4.  Prevalence and relation of dementia to various factors in Parkinson's disease.

Authors:  Abdul Qayyum Rana; Muhammad Saad Yousuf; Sughra Naz; Nour Qa'aty
Journal:  Psychiatry Clin Neurosci       Date:  2012-02       Impact factor: 5.188

Review 5.  Normal cognitive aging.

Authors:  Caroline N Harada; Marissa C Natelson Love; Kristen L Triebel
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

6.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

7.  Combined effect of age and severity on the risk of dementia in Parkinson's disease.

Authors:  Gilberto Levy; Nicole Schupf; Ming-Xin Tang; Lucien J Cote; Elan D Louis; Helen Mejia; Yaakov Stern; Karen Marder
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

8.  Excessive sleepiness is predictive of cognitive decline in the elderly.

Authors:  Isabelle Jaussent; Jean Bouyer; Marie-Laure Ancelin; Claudine Berr; Alexandra Foubert-Samier; Karen Ritchie; Maurice M Ohayon; Alain Besset; Yves Dauvilliers
Journal:  Sleep       Date:  2012-09-01       Impact factor: 5.849

9.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

10.  Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.

Authors:  Nor A Samat; Nor A Abdul Murad; Khairiyah Mohamad; Mohd R Abdul Razak; Norlinah Mohamed Ibrahim
Journal:  Front Neurosci       Date:  2017-12-20       Impact factor: 4.677

View more
  2 in total

1.  Partial correlation coefficient for a study with repeated measurements.

Authors:  Guogen Shan; Ece Bayram; Jessica Z K Caldwell; Justin B Miller; Jay J Shen; Shawn Gerstenberger
Journal:  Stat Biopharm Res       Date:  2020-07-20       Impact factor: 1.452

2.  Sex Differences in Patterns of Sleep Disorders Among Hospitalizations With Parkinson's Disease: 2004-2014 Nationwide Inpatient Sample.

Authors:  Hind A Beydoun; Sharmin Hossain; Shuyan Huang; May A Beydoun; Brook T Alemu; Shaker M Eid; Alan B Zonderman
Journal:  Psychosom Med       Date:  2021-06-01       Impact factor: 3.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.